Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.

Syndecan-1 (CD138) is a transmembrane proteoglycan expressed in various normal and malignant tissues. It is of interest due to a possible prognostic effect in tumors and its role as a target for the antibody-drug conjugate indatuximab ravtansine. Here, we analyzed 17,747 prostate cancers by immunohi...

Descripción completa

Detalles Bibliográficos

Publicado en:	BioMed Research International pp. 1 - 14
Autores principales:	Kind, Simon, Kluth, Martina, Hube-Magg, Claudia, Möller, Katharina, Makrypidi-Fraune, Georgia, Lutz, Florian, Lennartz, Maximilian, Rico, Sebastian Dwertmann, Schlomm, Thorsten, Heinzer, Hans, Höflmayer, Doris, Weidemann, Sören, Uhlig, Ria, Huland, Hartwig, Graefen, Markus, Bernreuther, Christian, Tsourlakis, Maria Christina, Minner, Sarah, Dum, David, Hinsch, Andrea
Formato:	pictorial research tables/charts Journal Article
Publicado:	Wiley-Blackwell 10/28/2020
Acceso en línea:	Ver este registro en EBSCOhost